| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042659 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 02/24/2005 | US20050042318 Controlling hormone sensitive diseases; solvent extraction of hops, filtration, desolventizing |
| 02/24/2005 | US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/24/2005 | US20050042311 Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells |
| 02/24/2005 | US20050042308 Soft capsules containing mint oil with analgesics, antiinflammatory agents ; complex |
| 02/24/2005 | US20050042280 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 02/24/2005 | US20050042237 Method for administering a spill resistant pharmaceutical system |
| 02/24/2005 | US20050042202 Gentamicin, amikacin, tobramycin, netilmicin, cephalosporin, ceftazidine, maxalactam, carbopenem, imipenem, aztreonam, ampicillin, penicillin, ureidopenicillin, augmentin, amphotericin, famvir and/or acyclovir; and Vpr protein, fragment or nucleic acid encoding; systemic inflammatory response syndrome |
| 02/24/2005 | US20050042173 Pharmaceuticals, cosmetics or nutraceuticals with a bioadhesive and plasticizer on a biodegradable support for transdermal or transmucosal application |
| 02/24/2005 | DE10335566A1 Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen Azolyl carbinols containing drug derivatives of aryl (or heteroaryl) |
| 02/24/2005 | CA2536146A1 Splice variants of erbb ligands, compositions and uses thereof |
| 02/24/2005 | CA2536073A1 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535613A1 Treatment of sleep disorders with cholinesterase inhibitors |
| 02/24/2005 | CA2535483A1 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 02/24/2005 | CA2535416A1 Imidazopyridine derivatives |
| 02/24/2005 | CA2535406A1 Gabanergic modulators |
| 02/24/2005 | CA2534887A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 02/24/2005 | CA2530604A1 Combinatorial synthesis on support |
| 02/24/2005 | CA2528192A1 Cristalline ziprasidone hcl and processes for preparation thereof |
| 02/24/2005 | CA2500358A1 Probes for diseases in which amyloid accumulates, agents for staining amyloid, drugs for treatment and prophylaxis of diseases with accumulated amyloid, and probes for diagnosis of neurofibrillary tangles and agents for staining neurofibrillary tangles |
| 02/23/2005 | EP1508336A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| 02/23/2005 | EP1507779A1 Inhibitors of jak and cdk2 protein kinases |
| 02/23/2005 | EP1507776A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/23/2005 | EP1507767A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors |
| 02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507754A1 Alkoxy aryl beta-2 adrenergic receptor agonists |
| 02/23/2005 | EP1507558A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507553A2 Pancreas-specific proteins |
| 02/23/2005 | EP1507551A2 The functional role and potential therapeutic use of pacap, vip and maxadilan in relation to adult neural stem or progenitor cells |
| 02/23/2005 | EP1507545A1 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere |
| 02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 02/23/2005 | EP1507537A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507536A2 Compositions and their uses for alleviating pain |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507529A1 Combination of organic compounds |
| 02/23/2005 | EP1507527A2 Methods for enhancing motor performance and/or endurance |
| 02/23/2005 | EP1507523A1 Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease |
| 02/23/2005 | EP1507519A1 Medicament with delayed release of the active substance, containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol |
| 02/23/2005 | EP1507518A1 Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 02/23/2005 | EP1507515A2 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 02/23/2005 | EP1395583B1 New phenylpiperazines |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | EP1261606B1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 02/23/2005 | EP1177177B1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/23/2005 | EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents |
| 02/23/2005 | EP1058544B1 Inhibition of tnf activity with compositions comprising heparin and soluble tnf recpetors |
| 02/23/2005 | EP1017381B1 Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome |
| 02/23/2005 | EP0854709B2 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 02/23/2005 | CN1585777A 肝脏x受体激动剂 Liver x receptor agonist |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585769A A2b adenosine receptor antagonists |
| 02/23/2005 | CN1585768A Pyrazole derivatives as psychopharmaceuticals |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585762A Pyridine derivatives as NMDA receptor ligands |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585753A Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 02/23/2005 | CN1585751A 喹啉化合物 Quinoline compound |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585748A NK1 antagonists |
| 02/23/2005 | CN1585747A Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1585648A Enamel matrix protein compositions for modulating immune response |
| 02/23/2005 | CN1585647A Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases |
| 02/23/2005 | CN1585646A Strontium compound for treatment of sub-dermal soft tissue pain |
| 02/23/2005 | CN1585642A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/23/2005 | CN1585641A Hydrazono-malonitriles |
| 02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1585635A 2-(4-isobutylphenyl) propionic acid medicinal composition |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1585627A Microfabricated nanopore device for sustained release of therapeutic agent |
| 02/23/2005 | CN1583747A Pterin mononitrogen monoxide synthase inhibitor |
| 02/23/2005 | CN1583746A Methylamino-pterin derivative with inhibiting nitric oxide synthetase function |
| 02/23/2005 | CN1583721A Synthesis of (S)-alpha-ethyl-2-oxi-1-pentazane acetamide |
| 02/23/2005 | CN1583155A Health care and refreshing brain towel treated with Chinse medicinal solution and its production |
| 02/23/2005 | CN1583127A Chinese medicine for tumour and depression and its preparation |
| 02/23/2005 | CN1583118A Oral tablets for relieving tobacco and its preparation |
| 02/23/2005 | CN1583116A Chinese medicinal composition for diseases of nervus, varscular headache, cerebral blood supply lack and sequel of apolexy |
| 02/23/2005 | CN1583072A Chinese medicinal for epilepsy and insanity |
| 02/23/2005 | CN1583070A Medicine for improving sleep and nourishing bowel and relieving constipation and its preparation |
| 02/23/2005 | CN1583066A Ointment for neuroparalysis |
| 02/23/2005 | CN1583036A Composite panaxadiol and saponin with physiologic activity and its use and preparation |
| 02/23/2005 | CN1583033A Pure Chinese herbal medicine for hydrocephalus and cerebral paralysis by washing feet |
| 02/23/2005 | CN1583031A Composite gastrodia luber medicine and its preparation and use |
| 02/23/2005 | CN1583018A Chinese medicinal composition for relieving alcoholism |
| 02/23/2005 | CN1582990A Beverage with Chinese medicines for relieving alcoholism |
| 02/23/2005 | CN1582980A Chinese medicinal composition for improving sleep and relaxing fatigue and its preparation |
| 02/23/2005 | CN1582979A Brain and intellectual health care medicine and its preparation |
| 02/23/2005 | CN1582975A Chinese medicine for diseases of cardio-cerebral blood vessels and its preparation |
| 02/23/2005 | CN1582948A Composite analgesic composition and its use |